Cracking the Code of Uncontrolled Hypertension

Published: 05 September 2024

  • Views:

    Views Icon 6539
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

If you missed the Symposium 'Cracking the Code of Uncontrolled Hypertension' at ESC 2024, the on-demand session is now available. 

 

Join Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof John Flack (Southern Illinois University School of Medicine, Springfield, US), Prof Alta Schutte (University of New South Wales, Sydney, AU), and Prof Bryan Williams (University College London, London, UK) as they explore the true clinical impact of uncontrolled hypertension, it's underlying pathophysiology and current treatment barriers, through interactive presentations, a case study and discussion. 

 

 

This activity is supported by an unrestricted educational grant from AstraZeneca. AstraZeneca has had no involvement in the selection of the speakers, the development of the activity, the agenda or the materials.

Learning Objectives

  • Describe the long-term clinical impact of uncontrolled hypertension
  • Apply guideline-directed management to a patient case study
  • Evaluate the challenges and limitations of current management options for uncontrolled hypertension
  • Describe the role of aldosterone in uncontrolled hypertension

Target Audience

  • Cardiologists
  • Hypertension specialists
  • Nephrologists
  • Primary Care Physicians
  • Pharmacists
  • HCPs

More from this programme

Part 1

Welcome and Introduction

Prof Thomas Weber introduces the Symposium and the panel.

Part 2

The True Impact of Uncontrolled Hypertension

In this episode Prof Weber and Prof Schutte examine the long-term clinical effects of unmanaged high blood pressure, emphasising guideline-directed management through the presentation of a case study.

Part 3

What Drives Uncontrolled Hypertension and What’s in Our Tool Kit?

In this presentation, Prof Williams explores the underlying causes of uncontrolled hypertension and reviews the available tools and strategies for effective management.

Part 4

Current Treatment Barriers and Limitations in Uncontrolled Hypertension

Prof Flack highlights the challenges healthcare providers face in achieving optimal blood pressure control.

Part 5

Summary and Close

The session concludes with a panel discussion and an interactive Q&A session, where the panelists address questions from the audience.

Faculty Biographies

Bryan  Williams

Bryan Williams

Chair of Medicine

Bryan Williams is Chair of Medicine at UCL and Chief Scientific and Medical Officer at the British Heart Foundation. He is also a Consultant Physician at University College London Hospitals (UCLH) where he was previously Director of the NIHR UCLH/UCL Biomedical Research Centre and Director of Research for UCLH (2014-2023).

Prof Williams research and specialist clinical practice is in the field of hypertension in which he is recognised as one of the world's leading authorities and is credited with driving changes in clinical practice globally. He has been a NHS Consultant Physician in front line care for 40 years. He has received numerous national and international awards and was the recipient of the Times Higher Education University award, for “Outstanding Innovation and Technology” 2011 and the Sleight Award (2014) by the European Society of Hypertension for his "outstanding contribution to research, education and clinical practice in the field of…

View full profile